Strong 3Q of Sopharma indicates better than expected FY 2016

Pharmaceuticals leader Sopharma booked a strong 3Q16 and is heading for a better than expected FY2016 performance. A new turning point for Sopharma After two years of disappointing performance due to heavy exposure to Russia and Ukraine, Sopharma’s latest results signal an inflection point into better times. 3Q16 top line and operating profitability improved considerably.… Read more